• Li Wang
Doctor of Pharmacy
President
Co-founder of WestChina-Frontier PharmaTech. 30 years' experience in drug safety and efficacy study management, PK/PD study and drug safety evaluation. 10 years' research and work experience in Japan academia. NMPA New Drug Reviewer. Ministry of Health of China Cosmetic Reviewer.
• Xiaobo Cen
Doctor of Toxicology
CEO
Co-founder of WestChina-Frontier PharmaTech. GLP regulation expert. 16 years' experience in drug safety and efficacy study management.
Research and work experience in Japan academia. NMPA New Drug Reviewer. NMPA New Drug Review Committee External Consultant.
• Hongxia Li
Master of Toxicology
Director of IACUC
Joined WestChina-Frontier PharmaTech early after its inception. GLP regulation expert. Laboratory animal regulation expert.
Over 30 years' experience in toxicology study management. Research and working experience in North America academia. AAALAC International Inspector. NMPA New Drug Reviewer.
• Hui Zhang
Doctor of Medicine
CSO
Dr. Hui Zhang has worked in pharmaceutical companies such as AstraZeneca and NovoNordisk for 20 Years.
She is a member of the Society of Toxicology pathology (STP), Society of European Toxicology Pathology (ESTP), Association of Inhalation Toxicology (AIT). She is a committee member of INHAND（International Harmonization of Nomenclature and Diagnostic Criteria） Special Sensory Working Group. Dr. Zhang is the CSO of WCFP as well as the director of pharmacology department.
• Bin Liu
Master of Toxicology
Deputy General Manager
Co-founder of WestChina-Frontier PharmaTech. Expert in domestic and international GLP regulations 18 years' experience in pre-clinical research and drug safety evaluation.
Working experience in NMPA New Drug Review Committee.
• Feng Chen
Doctor of Pharmacy & Transplantation Immunology
Director of QAU
Joined WestChina-Frontier PharmaTech early after its inception. GLP regulation expert. Over 10 years' experience of QAU
management. NMPA New Drug Reviewer.
• Bo Chen
Doctor of Toxicology
Director of Toxicology
Doctor in Drug and Instrument Evaluatio;CFDA-authorized expert in new drug evaluation ;
17-year experience as a study director and 5-year management experience of toxicology department;
Deputy Secretary-General of Reproductive Toxicology
Committee，Chinese Society of Toxicology.
• Chunyan Hu
Pathologist
Director of Pathology Lab
Founder of the WestChina-Frontier PharmaTech pathology team. GLP regulation expert. Over 30 years' experience in clinic
analysis and pathology analysis management. 10 years' research and work experience in North America academia. NMPA New Drug Reviewer.
